Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 01, 2023

Inhibiting VHL Protein‒Mediated Dishevelled Ubiquitination Protects Against Parkinson's Disease

Acta Pharmacologica Sinica


Additional Info

Acta Pharmacologica Sinica
Inhibiting von Hippel‒Lindau protein-mediated Dishevelled ubiquitination protects against experimental parkinsonism
Acta Pharmacol Sin 2023 May 01;44(5)940-953, J Shen, Q Zha, QH Yang, YQ Zhou, X Liang, YJ Chen, GX Qi, XJ Zhang, WB Yao, XD Gao, S Chen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading